136 related articles for article (PubMed ID: 32622430)
1. Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.
Tibaldi E; Gnudi F; Panzacchi S; Mandrioli D; Vornoli A; Manservigi M; Sgargi D; Falcioni L; Bua L; Belpoggi F
Acta Histochem; 2020 Jul; 122(5):151548. PubMed ID: 32622430
[TBL] [Abstract][Full Text] [Related]
2. Hemolymphoreticular Neoplasias from the Ramazzini Institute Long-term Mice and Rat Studies on Aspartame.
Gnudi F; Panzacchi S; Tibaldi E; Iuliani M; Sgargi D; Bua L; Mandrioli D
Ann Glob Health; 2023; 89(1):43. PubMed ID: 37362827
[TBL] [Abstract][Full Text] [Related]
3. Aspartame and cancer - new evidence for causation.
Landrigan PJ; Straif K
Environ Health; 2021 Apr; 20(1):42. PubMed ID: 33845854
[TBL] [Abstract][Full Text] [Related]
4. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.
Soffritti M; Belpoggi F; Tibaldi E; Esposti DD; Lauriola M
Environ Health Perspect; 2007 Sep; 115(9):1293-7. PubMed ID: 17805418
[TBL] [Abstract][Full Text] [Related]
5. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.
Soffritti M; Belpoggi F; Degli Esposti D; Lambertini L; Tibaldi E; Rigano A
Environ Health Perspect; 2006 Mar; 114(3):379-85. PubMed ID: 16507461
[TBL] [Abstract][Full Text] [Related]
6. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed.
Belpoggi F; Soffritti M; Padovani M; Degli Esposti D; Lauriola M; Minardi F
Ann N Y Acad Sci; 2006 Sep; 1076():559-77. PubMed ID: 17119233
[TBL] [Abstract][Full Text] [Related]
7. Histological analyses of the Ishii (1981) rat carcinogenicity study of aspartame and comparison with the Ramazzini Institute studies.
Shibui Y; Fujitani S; Iwata H; Lynch B; Roberts A
Regul Toxicol Pharmacol; 2019 Mar; 102():23-29. PubMed ID: 30572082
[TBL] [Abstract][Full Text] [Related]
8. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartame.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2023 Jan; 171():113504. PubMed ID: 36414169
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Cariostatic effect of aspartame in rats.
Das S; Das AK; Murphy RA; Warty S
Caries Res; 1997; 31(1):78-83. PubMed ID: 8955999
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran.
Asadi-Amoli F; Nozarian Z; Bonaki HN; Mehrtash V; Entezari S
Asian Pac J Cancer Prev; 2016; 17(8):3727-31. PubMed ID: 27644607
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
14. Commentary: further comments on Mycoplasma pulmonis and lymphoma in bioassays of rats.
Schoeb TR; McConnell EE
Vet Pathol; 2011 Mar; 48(2):420-6. PubMed ID: 20716760
[TBL] [Abstract][Full Text] [Related]
15. The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.
Soffritti M; Padovani M; Tibaldi E; Falcioni L; Manservisi F; Belpoggi F
Am J Ind Med; 2014 Apr; 57(4):383-97. PubMed ID: 24436139
[TBL] [Abstract][Full Text] [Related]
16. Aspartame and Risk of Cancer: A Meta-analytic Review.
Mallikarjun S; Sieburth RM
Arch Environ Occup Health; 2015; 70(3):133-41. PubMed ID: 24965331
[TBL] [Abstract][Full Text] [Related]
17. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
[TBL] [Abstract][Full Text] [Related]
18. Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring.
Nettleton JE; Cho NA; Klancic T; Nicolucci AC; Shearer J; Borgland SL; Johnston LA; Ramay HR; Noye Tuplin E; Chleilat F; Thomson C; Mayengbam S; McCoy KD; Reimer RA
Gut; 2020 Oct; 69(10):1807-1817. PubMed ID: 31996393
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of aspartame in rats not proven.
Magnuson B; Williams GM
Environ Health Perspect; 2008 Jun; 116(6):A239-40; author reply A240. PubMed ID: 18560494
[No Abstract] [Full Text] [Related]
20. Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study.
Bergstrom BP; Cummings DR; Skaggs TA
Neuropharmacology; 2007 Dec; 53(8):967-74. PubMed ID: 17976663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
